Michael Bergqvist

3.4k total citations
112 papers, 2.5k citations indexed

About

Michael Bergqvist is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Bergqvist has authored 112 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 44 papers in Oncology and 40 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Bergqvist's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (15 papers) and Glioma Diagnosis and Treatment (12 papers). Michael Bergqvist is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (15 papers) and Glioma Diagnosis and Treatment (12 papers). Michael Bergqvist collaborates with scholars based in Sweden, United Kingdom and United States. Michael Bergqvist's co-authors include Stefan Bergström, Simon Ekman, Daniel Brattström, Fredrik Pontén, Patrik Hesselius, Gunnar Wagenius, Anders Berglund, Georg Holgersson, Mats Lambe and Ola Brodin and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Michael Bergqvist

111 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Bergqvist Sweden 27 1.1k 873 686 579 384 112 2.5k
Jeremy Braybrooke United Kingdom 23 1.0k 0.9× 1.4k 1.6× 674 1.0× 979 1.7× 312 0.8× 64 2.9k
David Propper United Kingdom 24 1.1k 1.0× 1.3k 1.5× 374 0.5× 532 0.9× 662 1.7× 78 3.1k
Rafael Santana-Dávila United States 22 1.7k 1.5× 1.7k 1.9× 1.2k 1.7× 671 1.2× 283 0.7× 70 3.7k
Amanda J. Redig United States 22 1.2k 1.1× 1.5k 1.7× 1.5k 2.1× 648 1.1× 222 0.6× 39 3.1k
Yuan Yuan United States 30 1.5k 1.4× 1.7k 1.9× 735 1.1× 1.2k 2.1× 425 1.1× 168 3.6k
Sherry X. Yang United States 21 1.8k 1.6× 1.5k 1.7× 372 0.5× 904 1.6× 203 0.5× 54 3.2k
Sacha J. Howell United Kingdom 35 1.7k 1.5× 2.1k 2.4× 703 1.0× 1.0k 1.7× 247 0.6× 146 4.4k
Rachel Midgley United Kingdom 26 929 0.8× 1.7k 1.9× 440 0.6× 559 1.0× 349 0.9× 56 2.8k
Carmen S. Tellez United States 29 2.1k 1.9× 830 1.0× 400 0.6× 762 1.3× 457 1.2× 50 3.1k
Daniel G. Stover United States 26 1.3k 1.1× 1.5k 1.7× 658 1.0× 783 1.4× 373 1.0× 148 3.1k

Countries citing papers authored by Michael Bergqvist

Since Specialization
Citations

This map shows the geographic impact of Michael Bergqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bergqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bergqvist more than expected).

Fields of papers citing papers by Michael Bergqvist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Bergqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bergqvist. The network helps show where Michael Bergqvist may publish in the future.

Co-authorship network of co-authors of Michael Bergqvist

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Bergqvist. A scholar is included among the top collaborators of Michael Bergqvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Bergqvist. Michael Bergqvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bergström, Stefan, Georg Holgersson, Johanna Hök Nordberg, et al.. (2023). Use of CAM among cancer patients. BMC Complementary Medicine and Therapies. 23(1). 51–51. 14 indexed citations
2.
Berglund, Anders, Stefan Bergström, Johan Isaksson, et al.. (2022). Patterns of care and outcomes in immigrants with non-small cell lung cancer. A population-based study (Sweden). PLoS ONE. 17(12). e0278706–e0278706. 3 indexed citations
3.
Berglund, Anders, et al.. (2019). Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study. Lung Cancer. 131. 40–46. 21 indexed citations
4.
Djureinovic, Dijana, Tea Dodig‐Crnković, Cecilia Hellström, et al.. (2018). Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer. Lung Cancer. 125. 157–163. 18 indexed citations
5.
Nilsson, Jonas, et al.. (2016). The Use of Complementary and Alternative Medicine in Scandinavia.. PubMed. 36(7). 3243–51. 22 indexed citations
6.
Nilsson, Jonas, et al.. (2016). Incidence Rates in Low-Grade Primary Brain Tumors: Are There Differences Between Men and Women? A Systematic Review. World Journal of Oncology. 7(4). 59–69. 2 indexed citations
7.
Bergström, Tobias, Per‐Henrik Edqvist, Anders Lundequist, et al.. (2013). Glioma‐derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5‐dependent manner. Molecular Oncology. 8(1). 50–58. 36 indexed citations
8.
Lohr, Miriam, Karolina Edlund, Johan Botling, et al.. (2013). The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer. Cancer Letters. 333(2). 222–228. 146 indexed citations
9.
Wu, Xuping, Katarina Nordfjäll, Krister Karlsson, et al.. (2012). Telomerase antagonist imetelstat inhibits esophageal cancer cell growth and increases radiation-induced DNA breaks. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(12). 2130–2135. 25 indexed citations
10.
Wu, Xuping, Håkan Hedman, Michael Bergqvist, et al.. (2011). Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity. Acta Oncologica. 51(1). 69–76. 17 indexed citations
11.
Micke, Patrick, Karolina Edlund, Lars Holmberg, et al.. (2011). Gene Copy Number Aberrations Are Associated with Survival in Histologic Subgroups of Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(11). 1833–1840. 47 indexed citations
12.
Agnarsdóttir, Margrét, Linda Sooman, Sara Strömberg, et al.. (2010). SOX10 expression in superficial spreading and nodular malignant melanomas. Melanoma Research. 20(6). 468–478. 26 indexed citations
13.
Ekman, Simon, Jan‐Erik Frödin, Johan Harmenberg, et al.. (2010). Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma. Acta Oncologica. 50(3). 441–447. 41 indexed citations
14.
Göransson, Hanna, Karolina Edlund, Maria Rydåker, et al.. (2009). Quantification of Normal Cell Fraction and Copy Number Neutral LOH in Clinical Lung Cancer Samples Using SNP Array Data. PLoS ONE. 4(6). e6057–e6057. 17 indexed citations
15.
Wu, Xuping, Alkwin Wanders, Lars Gedda, et al.. (2009). Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin. British Journal of Cancer. 100(2). 334–343. 49 indexed citations
16.
Brattström, Daniel, Gunnar Wagenius, Per Sandström, et al.. (2005). Newly developed assay measuring cytokeratins 8, 18 and 19 in serum is correlated to survival and tumor volume in patients with esophageal carcinoma. Diseases of the Esophagus. 18(5). 298–303. 11 indexed citations
17.
Bergqvist, Michael, Daniel Brattström, David Brodin, et al.. (2005). Genes associated with telomerase activity levels in esophageal carcinoma cell lines. Diseases of the Esophagus. 19(1). 20–23. 6 indexed citations
18.
Wagenius, Gunnar, Stefan Bergström, Daniel Brattström, et al.. (2005). The Role of Cystatin C and the Angiogenic Cytokines VEGF and bFGF in Patients with Esophageal Carcinoma. Medical Oncology. 22(1). 29–38. 15 indexed citations
19.
Abramsson-Zetterberg, Lilianne, et al.. (2000). Human cytogenetic biomonitoring using flow-cytometric analysis of micronuclei in transferrin-positive immature peripheral blood reticulocytes. Environmental and Molecular Mutagenesis. 36(1). 22–31. 48 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeremy Braybrooke Breakdown of academic impact, for papers by David Propper Breakdown of academic impact, for papers by Rafael Santana-Dávila Breakdown of academic impact, for papers by Amanda J. Redig Breakdown of academic impact, for papers by Yuan Yuan Breakdown of academic impact, for papers by Sherry X. Yang Breakdown of academic impact, for papers by Sacha J. Howell Breakdown of academic impact, for papers by Rachel Midgley Breakdown of academic impact, for papers by Carmen S. Tellez Breakdown of academic impact, for papers by Daniel G. Stover
Rankless by CCL
2026